iRhythm Stock (NASDAQ:IRTC)
Previous Close
$100.75
52W Range
$55.92 - $128.52
50D Avg
$106.09
200D Avg
$88.54
Market Cap
$3.14B
Avg Vol (3M)
$426.32K
Beta
1.45
Div Yield
-
IRTC Company Profile
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
IRTC Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|
| Non-contracted Third-party Payors | $42.73M | $32.07M | $24.13M |
| Centers For Medicare And Medicaid | $142.39M | $122.41M | $103.03M |
| Commercial Payors | $311.61M | $267.19M | $223.98M |
| Healthcare Institutions | $95.11M | $71.00M | $59.77M |
Fiscal year ends in Dec 24 | Currency in USD